Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?

Medicina (Kaunas). 2021 Nov 27;57(12):1301. doi: 10.3390/medicina57121301.

Abstract

Biliary tract cancer (BTC) includes a heterogeneous group of aggressive and rare hepatobiliary malignancies, including gallbladder cancer, ampullary carcinomas, intrahepatic cholangiocarcinoma (iCCA), and extrahepatic cholangiocarcinoma, further subclassified into distal (dCCA) and perihilar cholangiocarcinoma (pCCA) [...].

MeSH terms

  • Bile Duct Neoplasms* / drug therapy
  • Bile Ducts, Intrahepatic
  • Biliary Tract Neoplasms* / drug therapy
  • Cholangiocarcinoma* / drug therapy
  • Humans